CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- In today's tough economy, maintaining operational efficiencies remains key, even while focusing on strategy and tactics to drive growth and profitability. In an effort to better understand the resources dedicated by biopharmaceutical companies to support marketing operations, a recent benchmark study was conducted by Best Practices, LLC, with insights available in the newly published report, "Benchmarks for Optimizing Marketing Staff Levels to Drive Growth." Data from this study were collected from more than sixty biopharma marketing leaders.
Benchmark data shares insights from a number of critical areas, including:
-- Staffing and productivity levels utilized across healthcare business models
-- Growth and profit margin levels across biopharma portfolios -- Strategic and tactical activities that drive profitability & growth
The metrics shared in this study, segmented across pharma/biotech, medical devices and generic products, were gathered from across the biopharma industry including such companies as Abbott, Amgen, Baxter, Johnson & Johnson, Novartis, Pfizer, Roche, and Sanofi-Aventis.
Key metrics found in the report include: -- Number of Products Supported Per Tactical Marketing FTE -- Number of Strategic Marketing FTEs per $100 Million -- Time & Activity Benchmarks for Strategic Marketing Staff -- Strategic Marketing Staff Benchmarks Across Key Activities -- Tactical Marketing Staff Benchmarks Across Key Activities
For more information on this report, contact Ben Gregory at email@example.com or (919) 767-9160. To access the full report or download a complimentary copy of the report summary, go to www.best-in-class.com/rr977.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.
|SOURCE Best Practices, LLC|
Copyright©2009 PR Newswire.
All rights reserved